MedTrace Logo

Efficacy of Chinese Herbal Medicine to Prevent and Treat COVID-19 Close Contacts

NCT05269511 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2163

Last updated 2023-04-20

No results posted yet for this study

Summary

This is a randomized, blank-controlled study in adults with household contact exposure to individuals with SARS-CoV-2 infection. All subjects in the study will be household contacts with close exposure to the first household member known to be newly infected with SARS-CoV-2. Subjects in each cohort will be randomly assigned to the Chinese herbal medicine treatment group or blank control group in a 4:1 ratio, followed by 1 week of the treatment period and 2 weeks of follow-up.

Conditions

  • Healthy Participants

Interventions

DRUG

Chinese herbal medicine is in the form of granules (9 g/sachet), which is comprised of ten medicinal herbs.

Oral administration, twice per day.

Sponsors & Collaborators

  • Hong Kong Baptist University

    lead OTHER

Principal Investigators

  • Aiping Lyu · School of Chinese Medicine, Hong Kong Baptist University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-03-14
Primary Completion
2022-06-22
Completion
2022-06-22

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05269511 on ClinicalTrials.gov